COVID-19重症患者接受肾脏替代治疗的急性肾损伤
这项多中心队列研究纳入美国67家医院ICU的3099例COVID-19重症成人患者,发现20.6%在入ICU 14天内发生需RRT的AKI,其中54.9%于28天内死亡。出院患者中33.8%出院时仍依赖RRT,18.1%在入ICU 60天后仍依赖RRT。
要点
- COVID-19重症患者中约五分之一发生需RRT的AKI。
- 需RRT的AKI患者28天死亡率达54.9%,总住院死亡率超60%。
- 出院幸存者中约三分之一出院时仍依赖RRT。
核心结论
- COVID-19重症患者中需RRT的AKI常见,且与超过60%的住院死亡率相关。
- 出院幸存者中约三分之一出院时仍依赖RRT,约六分之一在入ICU 60天后仍依赖RRT。
研究设计与样本
- 多中心队列研究,纳入美国67家医院ICU的3099例COVID-19重症成人患者。
- 采用多变量logistic回归分析AKI-RRT的患者及医院层面危险因素和28天死亡危险因素。
主要发现
- 3099例中637例(20.6%)在入ICU 14天内发生AKI-RRT,其中350例(54.9%)在入ICU 28天内死亡。
- AKI-RRT患者层面的危险因素包括CKD、男性、非白人种族、高血压、糖尿病、较高BMI、较高D-二聚体和入ICU时较低氧血症更严重。
- AKI-RRT患者28天死亡的预测因素包括高龄、严重少尿、入住ICU床位较少的医院或所在地区COVID-19密度较高。
- 中位随访17天(范围1-123天)时,637例AKI-RRT患者中403例(63.3%)死亡,216例(33.9%)出院,18例(2.8%)仍住院。
- 216例出院患者中,73例(33.8%)出院时仍依赖RRT,39例(18.1%)在入ICU 60天后仍依赖RRT。
临床怎么用
- 对COVID-19重症患者应警惕需RRT的AKI,尤其合并CKD、高血压、糖尿病、高BMI或高D-二聚体者。
- 对AKI-RRT幸存者出院时应评估RRT依赖状态并规划随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: AKI is a common sequela of coronavirus disease 2019 (COVID-19). However, few studies have focused on AKI treated with RRT (AKI-RRT). METHODS: We conducted a multicenter cohort study of 3099 critically ill adults with COVID-19 admitted to intensive care units (ICUs) at 67 hospitals across the United States. We used multivariable logistic regression to identify patient-and hospital-level risk factors for AKI-RRT and to examine risk factors for 28-day mortality among such patients. RESULTS: A total of 637 of 3099 patients (20.6%) developed AKI-RRT within 14 days of ICU admission, 350 of whom (54.9%) died within 28 days of ICU admission. Patient-level risk factors for AKI-RRT included CKD, men, non-White race, hypertension, diabetes mellitus, higher body mass index, higher d-dimer, and greater severity of hypoxemia on ICU admission. Predictors of 28-day mortality in patients with AKI-RRT were older age, severe oliguria, and admission to a hospital with fewer ICU beds or one with greater regional density of COVID-19. At the end of a median follow-up of 17 days (range, 1-123 days), 403 of the 637 patients (63.3%) with AKI-RRT had died, 216 (33.9%) were discharged, and 18 (2.8%) remained hospitalized. Of the 216 patients discharged, 73 (33.8%) remained RRT dependent at discharge, and 39 (18.1%) remained RRT dependent 60 days after ICU admission. CONCLUSIONS: AKI-RRT is common among critically ill patients with COVID-19 and is associated with a hospital mortality rate of >60%. Among those who survive to discharge, one in three still depends on RRT at discharge, and one in six remains RRT dependent 60 days after ICU admission.
引用
- Gupta S, Coca SG, Chan L, et al. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. J Am Soc Nephrol. 2020. PMID: 33067383. doi:10.1681/ASN.2020060897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。